Literature DB >> 24719425

Potential role for CA-SP in nucleating retroviral capsid maturation.

Matthew R England1, John G Purdy1, Ira J Ropson2, Paula M Dalessio2, Rebecca C Craven3.   

Abstract

UNLABELLED: During virion maturation, the Rous sarcoma virus (RSV) capsid protein is cleaved from the Gag protein as the proteolytic intermediate CA-SP. Further trimming at two C-terminal sites removes the spacer peptide (SP), producing the mature capsid proteins CA and CA-S. Abundant genetic and structural evidence shows that the SP plays a critical role in stabilizing hexameric Gag interactions that form immature particles. Freeing of CA-SP from Gag breaks immature interfaces and initiates the formation of mature capsids. The transient persistence of CA-SP in maturing virions and the identification of second-site mutations in SP that restore infectivity to maturation-defective mutant viruses led us to hypothesize that SP may play an important role in promoting the assembly of mature capsids. This study presents a biophysical and biochemical characterization of CA-SP and its assembly behavior. Our results confirm cryo-electron microscopy (cryo-EM) structures reported previously by Keller et al. (J. Virol. 87:13655-13664, 2013, doi:10.1128/JVI.01408-13) showing that monomeric CA-SP is fully capable of assembling into capsid-like structures identical to those formed by CA. Furthermore, SP confers aggressive assembly kinetics, which is suggestive of higher-affinity CA-SP interactions than observed with either of the mature capsid proteins. This aggressive assembly is largely independent of the SP amino acid sequence, but the formation of well-ordered particles is sensitive to the presence of the N-terminal β-hairpin. Additionally, CA-SP can nucleate the assembly of CA and CA-S. These results suggest a model in which CA-SP, once separated from the Gag lattice, can actively promote the interactions that form mature capsids and provide a nucleation point for mature capsid assembly. IMPORTANCE: The spacer peptide is a documented target for antiretroviral therapy. This study examines the biochemical and biophysical properties of CA-SP, an intermediate form of the retrovirus capsid protein. The results demonstrate a previously unrecognized activity of SP in promoting capsid assembly during maturation.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24719425      PMCID: PMC4054415          DOI: 10.1128/JVI.00309-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study.

Authors:  Carmen Butan; Parvez M Lokhandwala; John G Purdy; Giovanni Cardone; Rebecca C Craven; Alasdair C Steven
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

Review 3.  The molecular architecture of HIV.

Authors:  John A G Briggs; Hans-Georg Kräusslich
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

4.  Crystal structure of dimeric HIV-1 capsid protein.

Authors:  C Momany; L C Kovari; A J Prongay; W Keller; R K Gitti; B M Lee; A E Gorbalenya; L Tong; J McClure; L S Ehrlich; M F Summers; C Carter; M G Rossmann
Journal:  Nat Struct Biol       Date:  1996-09

5.  Second-site compensatory mutations of HIV-1 capsid mutations.

Authors:  Colleen M Noviello; Claudia S López; Ben Kukull; Henry McNett; Amelia Still; Jacob Eccles; Rachel Sloan; Eric Barklis
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

6.  Lethal mutations in the major homology region and their suppressors act by modulating the dimerization of the rous sarcoma virus capsid protein C-terminal domain.

Authors:  Paula M Dalessio; Rebecca C Craven; Parvez M Lokhandwala; Ira J Ropson
Journal:  Proteins       Date:  2012-11-05

7.  Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein.

Authors:  R C Craven; A E Leure-duPree; C R Erdie; C B Wilson; J W Wills
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Structure of full-length HIV-1 CA: a model for the mature capsid lattice.

Authors:  Barbie K Ganser-Pornillos; Anchi Cheng; Mark Yeager
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

9.  The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.

Authors:  Albert T Nguyen; Christa L Feasley; Ken W Jackson; Theodore J Nitz; Karl Salzwedel; Gillian M Air; Michael Sakalian
Journal:  Retrovirology       Date:  2011-12-07       Impact factor: 4.602

10.  Visualization of a missing link in retrovirus capsid assembly.

Authors:  Giovanni Cardone; John G Purdy; Naiqian Cheng; Rebecca C Craven; Alasdair C Steven
Journal:  Nature       Date:  2009-02-05       Impact factor: 49.962

View more
  4 in total

1.  RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.

Authors:  Simone Mattei; Annica Flemming; Maria Anders-Össwein; Hans-Georg Kräusslich; John A G Briggs; Barbara Müller
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Atomic Modeling of an Immature Retroviral Lattice Using Molecular Dynamics and Mutagenesis.

Authors:  Boon Chong Goh; Juan R Perilla; Matthew R England; Katrina J Heyrana; Rebecca C Craven; Klaus Schulten
Journal:  Structure       Date:  2015-06-25       Impact factor: 5.006

3.  Functional and Structural Characterization of Novel Type of Linker Connecting Capsid and Nucleocapsid Protein Domains in Murine Leukemia Virus.

Authors:  Michal Doležal; Romana Hadravová; Milan Kožíšek; Lucie Bednárová; Hana Langerová; Tomáš Ruml; Michaela Rumlová
Journal:  J Biol Chem       Date:  2016-08-11       Impact factor: 5.157

4.  In vitro assembly of the Rous Sarcoma Virus capsid protein into hexamer tubes at physiological temperature.

Authors:  Soumeya A Jaballah; Graham D Bailey; Ambroise Desfosses; Jaekyung Hyun; Alok K Mitra; Richard L Kingston
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.